Exploring Key Unmet Needs in Idiopathic Pulmonary Fibrosis : Episode 6

Managing Acute Exacerbations and the Psychosocial Aspect of Idiopathic and Progressive Pulmonary Fibrosis

August 1, 2024

Opinion

Video

An expert pulmonologist discusses the best ways to manage acute exacerbations and the psychosocial component of idiopathic and progressive pulmonary fibrosis.

EP: 1.Symptoms, Manifestations and Mortality Rate of IPF

EP: 2.How the GAP Program Helps Determine Patient Prognosis, and Risk Factors for Developing IPF/PPF

EP: 3.Epidemiology Facts, Differential Diagnosis, and Arriving at a IPF or PPF Diagnosis

EP: 4.Critical Early Diagnoses and Acute Exacerbations in IPF and PPF

EP: 5.Exploring the Role of Non-Pharmacological Modalities and Multidisciplinary Care in Patients with Idiopathic and Progressive Pulmonary Fibrosis

Now Viewing

EP: 6.Managing Acute Exacerbations and the Psychosocial Aspect of Idiopathic and Progressive Pulmonary Fibrosis

EP: 7.Key Unmet Needs Associated with Idiopathic and Progressive Pulmonary Fibrosis

EP: 8.The Roles of Biomarker Testing and HRCT in IPF and PPF

EP: 9.Unmet Needs and the Role of AI in Earlier Disease Detection

EP: 10.Adverse Events Associated with Anti-Fibrotic Therapies

EP: 11.Investigational Agents for Idiopathic and Progressive Pulmonary Fibrosis

EP: 12.The Future of Idiopathic and Progressive Pulmonary Fibrosis Treatment

EP: 13.K-Cast Written Summary. Exploring Key Unmet Needs in Idiopathic Pulmonary Fibrosis

How are acute exacerbations of IPF/PPF managed, and what is the role of corticosteroids?
What are the key pearls to managing the psychosocial aspects of this disease, such as depression, anxiety, and sleep disturbance?

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!